Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...

TCT 525: Cutting Balloon versus Standard Balloon for Lesion Preparation of Drug-Coated Balloon Treatment in De-novo Coronary Artery Lesions: Primary Endpoint of the Randomized NATURE Trial Receive the ...

Please provide your email address to receive an email when new articles are posted on . A novel implantable cardioverter defibrillator platform may benefit patients with HF not eligible for cardiac ...

Please provide your email address to receive an email when new articles are posted on . The Integra-D trial evaluated a novel implantable cardiac contractility modulation defibrillator for its ability ...

The American Medical Association’s CPT editorial panel will meet May 1-3 to consider codes for several devices and services, but the most important of these might be the code for cardiac contractility ...

MINNEAPOLIS — Switching candidates for implantable cardioverter-defibrillator (ICD) implantation to a dual-function device that also modulates cardiac contractility was associated with successful ...

JONESBORO, Ark. (KAIT) - One Northeast Arkansas hospital became the first in the state to successfully implant a new heart failure device. NEA Baptist announced they successfully implanted a Cardiac ...

The autonomic nervous system (ANS) is pivotal in maintaining cardiac homeostasis, intricately regulating heart rate, contractility, and vascular tone through its sympathetic and parasympathetic ...

Series A financing will advance the company’s lead candidate for heart failure with reduced ejection fraction (HFrEF) through completion of early clinical development and GMP manufacturing scale-up ...